Growth Metrics

Merck (MRK) Net Income Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -63.35%
Dec 31, 2025 41.45%
Sep 30, 2025 56.47%
Jun 30, 2025 46.29%
Mar 31, 2025 9.58%
Dec 31, 2024 32.41%
Sep 30, 2024 10.64%
Jun 30, 2024 15.61%
Mar 31, 2024 10.74%
Dec 31, 2023 -21.88%
Sep 30, 2023 19.39%
Jun 30, 2023 -40.42%
Mar 31, 2023 30.69%
Dec 31, 2021 36.21%
Jun 30, 2021 -22.78%
Mar 31, 2021 -17.30%
Dec 31, 2020 -11.84%
Sep 30, 2020 -19.55%
Jun 30, 2020 -0.80%
Mar 31, 2020 27.43%
Dec 31, 2019 -17.57%
Sep 30, 2019 17.76%
Jun 30, 2019 5.40%
Mar 31, 2019 10.58%
Dec 31, 2018 16.88%
Sep 30, 2018 11.23%
Jun 30, 2018 12.91%
Mar 31, 2018 -14.44%
Dec 31, 2017 -25.34%
Sep 30, 2017 -15.20%
Jun 30, 2017 1.40%
Mar 31, 2017 -2.51%
Dec 31, 2016 -18.94%
Sep 30, 2016 4.88%
Jun 30, 2016 -10.06%
Mar 31, 2016 1.08%
Dec 31, 2015 21.00%
Sep 30, 2015 37.54%
Jun 30, 2015 -2.48%
Mar 31, 2015 21.69%
Dec 31, 2014 -10.88%
Sep 30, 2014 23.16%
Jun 30, 2014 38.84%
Mar 31, 2014 16.61%